Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 10, 1998, Pages 1175-1179

  Nijs, N ^a   Duvaldestin, P ^a   Slavov, V ^a   Dhonneur, G ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Actracurium; Mivacurium; Monitoring; Neuromuscular relaxants; Pharmacodynamics; Tourniquet; Vecur onium

Indexed keywords

ATRACURIUM; MIVACURIUM; VECURONIUM;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG ELIMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

EID: 0031795082     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05272.x     Document Type: Article

References (13)

1. Bowman WC. Clinically used non-depolarising neuromuscular blocking drugs. In: Pharmacology of neuromuscular function. London: Wright, 1990: 168.
2. Bevan DR, Bevan JC, Donati F. Pharmacokinetic principles. In: Muscle relaxants in clinical anesthesia. Chicago: Year Book Medical Publishers, 1988: 100-132.
3. Ward S, Weatherley BC. Pharmacokinetics of atracurium and its metabolites. Br J Anaesth 1986: 58: 6S-10S.
4. Lynam DP, Cronnelly R, Castagnoli KP, Canfell PC, Caldwell J, Arden J et al. The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure. Anesthesiology 1988: 69: 227-231.
5. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1994: 80: 1296-1302.
6. Fisher DM. (Almost) Everything you learned about pharmacokinetics was (somewhat) wrong! Anesth Analg 1996: 83: 901-903.
7. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988: 68: 723-732.
8. Maddineni VR, Mirakhur RK, McCoy EP, Fee JPH, Clarke RSJ. Neuromuscular effects and intubating conditions following mivacurium: a comparison with suxamethonium. Anaesthesia 1993: 48: 940-945.
9. Robertson EN, Booij LHDJ, Frogen RS, Crul JF. Clinical comparison of atracurium and vecuronium (ORGNC45). Br J Anaesth 1983: 54: 125-129.
10. Feldman SA. Explanation of clinical events based on biophase binding. In: Feldman SA, ed. Neuromuscular block. Oxford: Butterworth, Heinemann, 1996: 61-71.
11. Viby-Mogensen J, Engbæk J, Eriksson LI, Gramstad L, Jensen E, Jensen FS et al. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuro muscular blocking agents. Acta Anaesthesiol Scand 1996: 40: 59-74.
12. Østergaard D, Jensen FS, Jensen E, Skovgård LT, Viby-Mogensen J. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase gene. Acta Anaesthesiol Scand 1993: 37: 314-318.
13. Østergaard D, Jensen FS, Jensen E, Skovgård LT, Viby-Mogensen J. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 1992: 36: 702-706.